|
Market Closed -
NYSE
16:04:30 2026-08-04 EDT
|
5-day change
|
1st Jan Change
|
|
332.88 USD
|
-0.55%
|
 |
+0.57%
|
+9.87%
|
|
08-04 |
Bio-Rad Laboratories Q2 Adjusted Earnings Rise, Revenue Falls
|
MT
| |
08-04 |
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q2 Revenue $651.0M, vs. FactSet Est of $624.0M
|
MT
| |
08-04 |
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q2 Adjusted EPS $2.62 per Share, vs. FactSet Est of $1.75
|
MT
| |
08-04 |
Bio-Rad Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
|
CI
| |
04-30 |
Bio-Rad Laboratories Q1 Adjusted Earnings Fall, Revenue Rises
|
MT
| |
04-30 |
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q1 Revenue $592.1M, vs. FactSet Est of $589.9M
|
MT
| |
04-30 |
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q1 Adjusted EPS $1.89 per Share, vs. FactSet Est of $1.97
|
MT
| |
04-30 |
Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.
|
CI
| |
04-30 |
Bio-Rad Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
|
CI
| |
02-12 |
Bio-Rad Laboratories Q4 Adjusted Earnings Fall, Revenue Rises; Shares Drop After Hours
|
MT
| |
02-12 |
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q4 Revenue $693.2M, vs. FactSet Est of $688.8M
|
MT
| |
02-12 |
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q4 Adjusted EPS $2.51 per Share, vs. FactSet Est of $2.71
|
MT
| |
02-12 |
Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.
|
CI
| |
02-12 |
Bio-Rad Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025
|
CI
| |
25-10-30 |
Bio-Rad Laboratories Q3 Non-GAAP Earnings, Revenue Rise
|
MT
| |
25-10-29 |
Bio-Rad Q3 profit beats estimates helped by cost management
|
RE
| |
25-10-29 |
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Reports Q3 Revenue $653.0M, vs. FactSet Est of $652.2M
|
MT
| |
25-10-29 |
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q3 Adjusted EPS $2.26 per Share, vs. FactSet Est of $1.95
|
MT
| |
25-10-29 |
Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.
|
CI
| |
25-10-29 |
Bio-Rad Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
|
CI
| |
25-10-16 |
Bio-Rad to report third quarter 2025 financial results
|
RE
| |
25-08-01 |
Bio-Rad Laboratories Shares Rise After Price Target Boosts Post-Q2 Beat
|
MT
| |
25-07-31 |
Bio-Rad Laboratories Q2 Tops Estimates; Updates Guidance
|
MT
| |
25-07-31 |
Bio-Rad Q2 revenue up 2.1%, beats estimates
|
RE
| |
25-07-31 |
Earnings Flash (BIO) Bio-Rad Laboratories, Inc. Posts Q2 Adjusted EPS $2.61 per Share, vs. FactSet Est of $1.73
|
MT
|
No results match your criteria Select your edition All financial news and data tailored to specific country editions | 
